• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Intelence (etravirine) 100 mg tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2010


Summary View



Table 3: Established and Other Potentially Significant Drug Interactions: Alterations in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted Interaction

the following drug interactions were updated in the table:

  • between etravirine and fluconazole 
  • voriconazole 
  • lopinavir/ritonavir and 
  • clopidogrel 
  • and to include information on coadministration of protease inhibitors with or without ritonavir